Abstract #4205
Protein MRI Contrast Agents (ProCAs) with Unique Capability in Early detection and Molecular Imaging of Varies Types of Cancer
Jenny Yang 1,2 , Jingjuan Qiao 1 , Shenghui Xue 1 , Fan Pu 1 , Shanshan Tan 1 , Jie Jiang 1 , Anvi Patel 1 , and Zhi-ren Liu 2,3
1
Chemistry Department, Georgia State
University, Atlanta, Georgia, United States,
2
Center
for Diagnostics and Therapeutics, Georgia State
University, Atlanta, Georgia, United States,
3
Biology
Department, Georgia State University, Atlanta, Georgia,
United States
This research focuses on developing rational protein
based MRI contrast agents for cancer imaging. Various
cancer models including breast cancer, prostate cancer
and liver cancers have been successfully imaged with
high sensitive and resolution under MRI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
